{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:01:12Z","timestamp":1769835672579,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.farma.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T06:14:51Z","timestamp":1694240091000},"page":"T190-T195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["[Translated article] Influence of augmented renal clearance in the lower incidence of linezolid-related haematological toxicity"],"prefix":"10.1016","volume":"47","author":[{"given":"Beatriz","family":"S\u00e1nchez-Sanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Caro-Teller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Gonz\u00e1lez-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Pablo","family":"Rodr\u00edguez-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Hern\u00e1ndez-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Ferrari-Piquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2023.08.003_bb0005","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"10.1016\/j.farma.2023.08.003_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.eimc.2009.02.004","article-title":"Oxazolidinonas, glucop\u00e9ptidos y lipop\u00e9ptidos c\u00edclicos","volume":"27","author":"Pigrau","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"2","key":"10.1016\/j.farma.2023.08.003_bb0015","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1016\/j.farma.2023.08.003_bb0020","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.farma.2023.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-017-2960-5","article-title":"Predictive score of haematological toxicity in patients treated with linezolid","volume":"36","author":"Gonz\u00e1lez-Del Castillo","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.farma.2023.08.003_bb0030","doi-asserted-by":"crossref","first-page":"e00605","DOI":"10.1128\/AAC.00605-19","article-title":"Reappraisal of linezolid dosing in renal impairment to improve safety","volume":"63","author":"Crass","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.farma.2023.08.003_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/498509","article-title":"High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease","volume":"42","author":"Wu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.farma.2023.08.003_bb0040","doi-asserted-by":"crossref","first-page":"723731","DOI":"10.3389\/fphar.2021.723731","article-title":"Augmented renal clearance: what have we known and what will we do?","volume":"12","author":"Luo","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.farma.2023.08.003_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijid.2020.02.044","article-title":"Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic\/pharmacodynamic perspective","volume":"93","author":"Barrasa","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.farma.2023.08.003_bb0050","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","article-title":"Augmented renal clearance in critically ill patients: a systematic review","volume":"57","author":"Bilbao-Meseguer","year":"2018","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"10.1016\/j.farma.2023.08.003_bb0055","first-page":"344","article-title":"Estimation of glomerular filtration rate with creatinine","volume":"146","author":"Huidobro","year":"2018","journal-title":"Rev. Med Chil."},{"issue":"1","key":"10.1016\/j.farma.2023.08.003_bb0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"3","key":"10.1016\/j.farma.2023.08.003_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0039-1697930","article-title":"Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics","volume":"46","author":"Danese","year":"2020","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.farma.2023.08.003_bb0075","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","first-page":"155","year":"2017"},{"key":"10.1016\/j.farma.2023.08.003_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2015.06.002","article-title":"Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization","volume":"24","author":"Sime","year":"2015","journal-title":"Curr Opin Pharmacol."},{"issue":"1","key":"10.1016\/j.farma.2023.08.003_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/viru.27135","article-title":"Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?","volume":"5","author":"Balk","year":"2014","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.farma.2023.08.003_bb0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/antibiotics10050530","article-title":"Clinical use and adverse drug reactions of linezolid: a retrospective study in four Belgian Hospital Centers","volume":"10","author":"Thirot","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"10.1016\/j.farma.2023.08.003_bb0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.farma.2023.08.003_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/DDDT.S303497","article-title":"Pharmacokinetics of linezolid dose adjustment for creatinine clearance in critically ill patients: a multicenter, prospective, open-label, observational study","volume":"15","author":"Wang","year":"2021","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.farma.2023.08.003_bb0120","doi-asserted-by":"crossref","unstructured":"Luque S, Hope W, Sorli L, Mu\u00f1oz-Bermudez R, Campillo N, Barcel\u00f3-Vidal J, et al. Dosage individualization of linezolid: precision dosing of linezolid to optimize efficacy and minimize toxicity. Antimicrob Agents Chemother. 65(6):e02490-20.","DOI":"10.1128\/AAC.02490-20"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:50Z","timestamp":1761106670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634323001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1130634323001216"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2023.08.003","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Influence of augmented renal clearance in the lower incidence of linezolid-related haematological toxicity","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.04.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}